Adrenal Glands pp 201-209 | Cite as

Benign Paragangliomas

  • Abbie L. Young
  • William F. YoungJr.


Multiple Endocrine Neoplasia Type Neck Paragangliomas Mayo Clinic Series Carney Triad Bilateral Adrenal Neoplasm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Skoldberg F, Husebye E, Eng C, Maher ER (2001) Gene mutation in the succinate dehydrogenase subunit SDHB causes susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 69:49–54CrossRefPubMedGoogle Scholar
  2. 2.
    Atuk NO, Stolle C, Owen JA Jr, Carpenter JT, Vance ML (1998) Pheochromocytoma in von Hippel-Lindau disease: clinical presentation and mutation analysis in a large multigenerational kindred. J Clin Endocrinol Metab 83: 117–120CrossRefPubMedGoogle Scholar
  3. 3.
    Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PEM, Rubinstein WS, Myers EN, Richard CW 3rd, Cornelisse CJ, Devilee P, Devlin B (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287:848–851CrossRefPubMedGoogle Scholar
  4. 4.
    Baysal BE, Willett-Brozick JE, Lawrence EC, Drovdlic CM, Savul SA, McLeod DR, Yee HA, Brackmann DE, Slattery WH 3rd, Myers EN, Ferrell RE, Rubinstein WS (2002) Prevalence of SDHB, SDHC and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet 39:178–183CrossRefPubMedGoogle Scholar
  5. 5.
    Beard CM, Sheps SG, Kurland LT, Carney JA, Lie JT (1983) Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 58:802–804PubMedGoogle Scholar
  6. 6.
    Brantigan CO, Katase RY (1969) Clinical and pathologic features of paragangliomas of the organ of Zuckerkandl. Surgery 65:898–905PubMedGoogle Scholar
  7. 7.
    Bravo EL (2002) Pheochromocytoma: an approach to antihypertensive management. Ann N Y Acad Sci 970:1–10PubMedGoogle Scholar
  8. 8.
    Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL (2003) Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst 95:1196–1204PubMedGoogle Scholar
  9. 9.
    Carney JA (1999) Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney triad): natural history, adrenocortical component, and possible familial occurrence. Mayo Clin Proc 74:543–552PubMedGoogle Scholar
  10. 10.
    Chatal JF, Charbonnel B (1985) Comparison of iodobenzylguanidine imaging with computed tomography in locating pheochromocytoma. J Clin Endocrinol Metab 61: 796–772Google Scholar
  11. 11.
    Combemale F, Carnaille B, Tavernier B, Hautier MB, Thevenot A, Scherpereel P, Proye C (1998) Exclusive use of calcium channel blockers and cardioselective betablockers in the pre-and per-operative management of pheochromocytomas. 70 cases. Ann Chir 52:341–345PubMedGoogle Scholar
  12. 12.
    Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, van Amstel HK, Lips CJ, Nishisho I, Takai SI, Marsh DJ, Robinson BG, Frank-Raue K, Raue F, Xue F, Noll WW, Romei C, Pacini F, Fink M, Niederle B, Zedenius J, Nordenskjold M, Komminoth P, Hendy GN, Mulligan LM, et al. (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET mutation consortium analysis. JAMA 276:1575–1579CrossRefPubMedGoogle Scholar
  13. 13.
    Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, Young WF Jr (2001) Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 86:5210–5216CrossRefPubMedGoogle Scholar
  14. 14.
    Fries JG, Chamberlin JA (1968) Extra-adrenal pheochromocytoma: literature review and report of a cervical pheochromocytoma. Surgery 63:268–279Google Scholar
  15. 15.
    Hes FJ, Hoppener JW, Lips CJ (2003) Clinical review 155: Pheochromocytoma in Von Hippel-Lindau disease. J Clin Endocrinol Metab 88:969–974CrossRefPubMedGoogle Scholar
  16. 16.
    Ilias I, Yu J, Carrasquillo JA, Chen CC, Eisenhofer G, Whatley M, McElroy B, Pacak K (2003) Superiority of 6-[(18)F]-fluorodopamine positron emission tomography versus [(131)I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 88:4083–4087CrossRefPubMedGoogle Scholar
  17. 17.
    Jackson JA, Kleerekoper M, Mendlovic D (1993) Endocrine grand rounds: A 51-year-old man with accelerated hypertension, hypercalcemia, and right adrenal and paratracheal masses. Endocrinologist 3:5Google Scholar
  18. 18.
    Jalil ND, Pattou FN, Combemale F, Chapuis Y, Henry JF, Peix JL, Proye CA (1998) Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 cases. Eur J Surg 164:23–28PubMedGoogle Scholar
  19. 19.
    Januszewicz A, Neumann HP, Lon I, Szmigielski C, Symonides B, Kabat M, Apel TW, Wocial B, Lapinski M, Januszewicz W (2000) Incidence and clinical relevance of RET proto-oncogene germline mutations in pheochromocytoma patients. J Hypertens 18:1019–1023CrossRefPubMedGoogle Scholar
  20. 20.
    Kinney MA, Warner ME, van Heerden JA, Horlocker TT, Young WF Jr, Schroeder DR, Maxson PM, Warner MA (2000) Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesth Analgesia 91:1118–1123CrossRefGoogle Scholar
  21. 21.
    Kudva YC, Sawka AM, Young WF Jr (2003) The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab (in press)Google Scholar
  22. 22.
    Lack EE (2000) Tumours of adrenal and extra-adrenal paraganglia. In: Solae E, Kloppel G, Sobin LH (eds) Histological typing of endocrine tumors, 2nd edn. Springer, Berlin, pp 38–48Google Scholar
  23. 23.
    Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G (2002) Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287:1427–1434CrossRefPubMedGoogle Scholar
  24. 24.
    Maurea S, Coucolo A, Reynolds JC, Neumann RD, Salvatore M (1996) Diagnostic imaging in patients with paragangliomas. Computed tomography,magnetic resonance and MIGB scintigraphy comparison. Q J Nucl Med 40: 365–371PubMedGoogle Scholar
  25. 25.
    Melicow MM (1977) One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Presbyterian Medical Center, 1926–1976: a clinicopathological analysis. Cancer 40:1987–2004PubMedGoogle Scholar
  26. 26.
    Milunsky JM, Maher TA, Michels VV, Milunsky A (2001) Novel mutations and the emergence of a common mutation in the SDHD chain causing familial paraganglioma. Am J Med Genet 100:311–314CrossRefPubMedGoogle Scholar
  27. 27.
    Modlin IM, Farndon JR, Shepherd A, Johnston ID, Kennedy TL, Montgomery DA, Welbourn RB (1979) Phaeochromocytomas in 72 patients: clinical and diagnostic features, treatment and long term results. Br J Surg 66:456–465PubMedGoogle Scholar
  28. 28.
    Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peczkowska M, Szmigielski C, Eng C; Freiburg-Warsaw-Columbus Pheochromocytoma Study Group (2002) Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346: 1459–1466CrossRefPubMedGoogle Scholar
  29. 29.
    Niemann S, Muller U (2000) Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 26:268–270CrossRefPubMedGoogle Scholar
  30. 30.
    O’Riordain DS, Young WF Jr, Grant CS, Carney JA, van Heerden JA (1996) Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg 20:916–921CrossRefPubMedGoogle Scholar
  31. 31.
    O’Riordan JA (1997) Pheochromocytomas and anesthesia. Int Anesthesiol Clin 25:99–127Google Scholar
  32. 32.
    Sawka AM, Jaeschke R, Singh RJ, Young WF Jr (2003) A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88:553–558CrossRefPubMedGoogle Scholar
  33. 33.
    Shapiro B, Gross MD, Fig L, et al. (1990) In: Endocrine hypertension. Raven Press, New York, p 235Google Scholar
  34. 34.
    Stenstrom G, Svardsudd K (1986) Pheochromocytoma in Sweden 1958–1981. An analysis of the National Cancer Registry Data. Acta Med Scand 220:225–232PubMedGoogle Scholar
  35. 35.
    Taschner PE, Jansen JC, Baysal BE, Bosch A, Rosenberg EH, Brocker-Vriends AH, van Der Mey AG, van Ommen GJ, Cornelisse CJ, Devilee P (2001) Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer 31:274–281CrossRefPubMedGoogle Scholar
  36. 36.
    Trobs RB, Reichardt P, Friedrich T, Kloppel R, Bennek J (2002) Pheochromocytoma and multifocal functioning paraganglioma in a 9-year-old boy with von Hippel-Lindau disease. Urol Int 68:299–301CrossRefPubMedGoogle Scholar
  37. 37.
    Ulchaker JC, Goldfarb DA, Bravo EL, Novick AC (1999) Successful outcomes in pheochromocytoma surgery in the modern era. J Urol 161:764–767CrossRefPubMedGoogle Scholar
  38. 38.
    van Gils AP, Falke TH, van Erkel AR, Arndt JW, Sandler MP, van der Mey AG, Hoogma RP (1991) MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas. Radiographics 11: 37–57PubMedGoogle Scholar
  39. 39.
    van Heerden JA, Roland CF, Carney JA, Sheps SG, Grant CS (1990) Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s). World J Surg 14:325–329CrossRefPubMedGoogle Scholar
  40. 40.
    Whalen RK, Althausen AF, Daniels GH (1992) Extraadrenal pheochromocytoma. J Urol 147:1–10PubMedGoogle Scholar
  41. 41.
    Young AL, Baysal BE, Deb A, Young WF Jr (2002) Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene. J Clin Endocrinol Metab 87:4101–4105CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Abbie L. Young
  • William F. YoungJr.

There are no affiliations available

Personalised recommendations